Literature DB >> 16474844

Tumor suppressor p53 regulates heparanase gene expression.

L Baraz1, Y Haupt, M Elkin, T Peretz, I Vlodavsky.   

Abstract

Mammalian heparanase degrades heparan sulfate, the most prominent polysaccharide of the extracellular matrix. Causal involvement of heparanase in tumor progression is well documented. Little is known, however, about mechanisms that regulate heparanase gene expression. Mutational inactivation of tumor suppressor p53 is the most frequent genetic alteration in human tumors. p53 is a transcription factor that regulates a wide variety of cellular promoters. In this study, we demonstrate that wild-type (wt) p53 binds to heparanase promoter and inhibits its activity, whereas mutant p53 variants failed to exert an inhibitory effect. Moreover, p53-H175R mutant even activated heparanase promoter activity. Elimination or inhibition of p53 in several cell types resulted in a significant increase in heparanase gene expression and enzymatic activity. Trichostatin A abolished the inhibitory effect of wt p53, suggesting the involvement of histone deacetylation in negative regulation of the heparanase promoter. Altogether, our results indicate that the heparanase gene is regulated by p53 under normal conditions, while mutational inactivation of p53 during cancer development leads to induction of heparanase expression, providing a possible explanation for the frequent increase of heparanase levels observed in the course of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474844     DOI: 10.1038/sj.onc.1209425

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation.

Authors:  Geetha Rao; Dingxie Liu; Mingzhao Xing; Jordi Tauler; Richard A Prinz; Xiulong Xu
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Inhibition of heparanase protects against pancreatic beta cell death in streptozotocin-induced diabetic mice via reducing intra-islet inflammatory cell infiltration.

Authors:  Wen-Yu Song; Xiao-Han Jiang; Ying Ding; Yan Wang; Ming-Xuan Zhou; Yun Xia; Chen-Yu Zhang; Chong-Chong Yin; Chen Qiu; Kai Li; Peng Sun; Xiao Han
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

3.  Novel 1, 3-N, O-Spiroheterocyclic compounds inhibit heparanase activity and enhance nedaplatin-induced cytotoxicity in cervical cancer cells.

Authors:  Yanan Song; Bin Hu; Hongjie Qu; Lu Wang; Yunxiao Zhang; Jinchao Tao; Jinquan Cui
Journal:  Oncotarget       Date:  2016-06-14

4.  Involvement of Ext1 and heparanase in migration of mouse FBJ osteosarcoma cells.

Authors:  Yinan Wang; XiaoYan Yang; Sadako Yamagata; Tatsuya Yamagata; Toshinori Sato
Journal:  Mol Cell Biochem       Date:  2012-10-10       Impact factor: 3.396

5.  Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1.

Authors:  Jianping Li; Xin Meng; Jing Hu; Ying Zhang; Yunzhi Dang; Lichun Wei; Mei Shi
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

6.  Significance of heparanase in metastatic lymph nodes of cervical squamous cell cancer.

Authors:  Bin Hu; Qing Wang; Yingying Shi; Shufang Lu; Hongjie Qu; Lu Wang; Jinquan Cui
Journal:  Oncol Lett       Date:  2017-03-06       Impact factor: 2.967

Review 7.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

Review 8.  Versatile role of heparanase in inflammation.

Authors:  Rachel Goldberg; Amichay Meirovitz; Nir Hirshoren; Raanan Bulvik; Adi Binder; Ariel M Rubinstein; Michael Elkin
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

Review 9.  Heparanase in inflammation and inflammation-associated cancer.

Authors:  Amichay Meirovitz; Rachel Goldberg; Adi Binder; Ariel M Rubinstein; Esther Hermano; Michael Elkin
Journal:  FEBS J       Date:  2013-03-04       Impact factor: 5.542

Review 10.  Heparanase enzyme in chronic inflammatory bowel disease and colon cancer.

Authors:  Esther Hermano; Immanuel Lerner; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2012-02-14       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.